New Key Statistics Module, Z-Score and F-Score
NAS:AMLX Key Ratios
| Market Cap $ M | 265.28 |
| Enterprise Value $ M | 47.16 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.35 |
| Price/Sales | 1.35 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 196.00 |
| EPS (TTM) $ | -3.82 |
| Beneish M-Score | -5.34 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.16 |
| EV-to-EBITDA | -0.16 |
| PEG | -- |
| Shares Outstanding M | 68.55 |
| Net Margin (%) | -132.05 |
| Operating Margin % | -108.45 |
| Pre-tax Margin (%) | -131.04 |
| Quick Ratio | 4.55 |
| Current Ratio | 4.55 |
| ROA % (ttm) | -65.38 |
| ROE % (ttm) | -79.41 |
| ROIC % (ttm) | -516.65 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.95 |
AMLX Number of Guru Trades
AMLX Volume of Guru Trades
Gurus Latest Trades with NAS:AMLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AMLX is held by these investors
Total 1
Amylyx Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:AMLX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers